RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in RVL Pharmaceuticals plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +8 vs. Q2 2022
- Shares held
- 24.0M
- +7.68M (+46.9%) vs. Q2 2022
- Total value
- $50.5M
- +$28.3M (+127.4%) vs. Q2 2022
- New holders
- 15
- 8 more added
- Sold out
- 7
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 7 | $15 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 294 | $1.00K | 0.00% | +210+250.0% | Added |
| Tilia Fiduciary Partners, Inc. | 435 | $1.00K | 0.00% | +435 | New |
| Advisor Group Holdings, Inc. | 1,187 | $2.00K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 306 | $2.00K | 0.00% | +306 | New |
| Huntington National Bank | 1,650 | $3.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,720 | $4.00K | 0.00% | +1,719+171,900.0% | Added |
| Barclays PLC | 2,849 | $6.00K | 0.00% | +2,849 | New |
| Tower View Investment Management & Research LLC | 4,100 | $9.00K | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 8,356 | $18.0K | 0.00% | +8,356 | New |
| SFMG, LLC | 10,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,394 | $23.0K | 0.00% | +11,169+4,964.0% | Added |
| Ergoteles LLC | 10,927 | $23.0K | 0.00% | +10,927 | New |
| Marshall Wace, LLP | 11,300 | $24.0K | 0.00% | +11,300 | New |
| Bank of New York Mellon Corp | 12,078 | $25.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,322 | $28.0K | 0.00% | −19,391−59.3% | Reduced |
| Two Sigma Advisers, LP | 14,100 | $30.0K | 0.00% | −3,300−19.0% | Reduced |
| Susquehanna International Group, LLP | 14,663 | $31.0K | 0.00% | +14,663 | New |
| Tower Research Capital LLC (TRC) | 15,483 | $32.0K | 0.00% | +15,483 | New |
| Two Sigma Securities, LLC | 16,298 | $34.0K | 0.00% | +16,298 | New |
| IPG Investment Advisors LLC | 17,500 | $36.8K | 0.01% | +17,500 | New |
| Citadel Advisors LLC | 21,561 | $46.0K | 0.00% | +21,561 | New |
| Virtu Financial LLC | 22,835 | $48.0K | 0.00% | +22,835 | New |
| Wells Fargo & Company | 23,717 | $49.0K | 0.00% | −157−0.7% | Reduced |
| Atria Wealth Solutions, Inc. | 27,000 | $56.7K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 29,519 | $62.0K | 0.00% | +29,519 | New |
| Insight Advisors, LLC | 37,823 | $79.0K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 64,472 | $135.0K | 0.00% | −6,619−9.3% | Reduced |
| State Street Corp | 72,187 | $152.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 86,361 | $182.0K | 0.00% | +13,738+18.9% | Added |
| Titleist Asset Management, Ltd. | 98,151 | $206.0K | 0.05% | −20,152−17.0% | Reduced |
| Marietta Wealth Management, LLC | 120,000 | $252.0K | 0.06% | 00.0% | Unchanged |
| Millennium Management LLC | 162,228 | $341.0K | 0.00% | +114,103+237.1% | Added |
| Worth Venture Partners, LLC | 185,647 | $390.0K | 0.24% | +185,647 | New |
| BlackRock Inc. | 201,419 | $423.0K | 0.00% | −5,759−2.8% | Reduced |
| Vanguard Group Inc | 222,435 | $467.0K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 276,428 | $580.0K | 0.01% | +276,428 | New |
| Geode Capital Management, LLC | 304,382 | $639.0K | 0.00% | +41,605+15.8% | Added |
| AIGH Capital Management LLC | 739,531 | $1.55M | 0.61% | +654,538+770.1% | Added |
| Renaissance Technologies LLC | 772,007 | $1.62M | 0.00% | −68,500−8.1% | Reduced |
| Morgan Stanley | 1,173,204 | $2.46M | 0.00% | −47,549−3.9% | Reduced |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $3.41M | 0.04% | 00.0% | Unchanged |
| Rovida Advisors Inc. | 3,000,000 | $6.30M | 2.93% | 00.0% | Unchanged |
| Athyrium Capital Management, LP | 14,600,444 | $30.7M | 11.48% | +6,451,612+79.2% | Added |
| Prudential Financial Inc | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −22,413−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −21,870−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,598−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −75−100.0% | Sold out |